Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 65   

Articles published

PFE 36.85 +0.02 (0.05%)
price chart
Pfizer Posts Strong Profits, Faces Strong Headwinds
Steps are being made in a positive direction, as Pfizer plans to spin off up to 20 percent of its animal health business in an initial public offering (IPO) this August.
Pfizer IPO, Cost Cuts Yield Time to Reinvent Its Research  Bloomberg
Business Day|Cost-Cutting Helps Pfizer Beat Analysts' Expectations  New York Times
PFE Breaking Out After Long Series of Corrections
Pfizer Inc. (NYSE:PFE) - This is the world's largest pharmaceutical company producing a wide range of drugs. In October 2009, it acquired Wyeth.
Pfizer sued by retailers for generic Lipitor delay
Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of generic versions of Lipitor, the best-selling drug in history.
Retailers sue Pfizer, charge generic Lipitor delay  Inquirer.net
Pharmacies Sue Pfizer Over Lipitor  Wall Street Journal
Is Pfizer A Good Buy?
Pfizer has been involved in a series of acquisitions and sell offs, some cheered and some criticized by investors. They recently sold off their nutrition business to Nestle for $11.9 billion.
Pfizer Announces Topline Results Of First Of Four Studies In Bapineuzumab ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in the Janssen Alzheimer Immunotherapy R&D LLC ...
Hopes dim for Alzheimer's trials after Pfizer failure  Reuters UK
Pfizer-Janssen Alzheimer's Treatment Misses Phase III Endpoints  Genetic Engineering News
Pfizer Wins Patent Ruling, Exclusive Sales for Lyrica
Pfizer Inc., the world's largest drugmaker, convinced a U.S. judge that its patents for the pain-drug Lyrica are valid and infringed, giving it exclusive sales rights until 2018.
Judge Rules Pfizer's Lyrica Patents Are Valid  Law360 (subscription)
Pfizer Wins Lyrica Patent Ruling  Wall Street Journal
For Pfizer, Boston's medical labs a lure
Pfizer Inc., the world's largest pharmaceutical company, has a storied history of hunting for blockbuster drugs in its own labs.
Pfizer Loses Prempro Ruling, Must Pay $10.4 Million
Jurors properly awarded Audrey Singleton, who sued Pfizer's Wyeth unit over Prempro, compensatory and punitive damages for the company's marketing of the drug, the Pennsylvania Superior Court ruled yesterday. Singleton's lawyers alleged that Wyeth hid ...
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.
Travelers Sues Pfizer For $47M Over Epilepsy Drug
Law360, New York (July 18, 2012, 11:09 PM ET) -- Travelers Indemnity Co. and several of its affiliates on Wednesday filed a $47 million suit against Pfizer Inc. claiming they overpaid for epilepsy drug Neurontin because of its anti-competitive efforts ...